GGT: what your result means.

Gamma-glutamyl transferase (GGT) is a liver enzyme involved in glutathione metabolism, the body's master antioxidant system. It rises with alcohol load, fatty liver, bile-duct stress and oxidative stress.

Why GGT matters

GGT is more than an alcohol marker: prospective cohorts show it independently predicts cardiovascular mortality and type 2 diabetes even at levels within the reference range, likely reflecting oxidative stress and early metabolic liver dysfunction. Paired with ALT, it distinguishes patterns a single enzyme cannot.

Associated risks when out of range: Oxidative stress, Alcohol-related liver strain. Metabolic risk.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets GGT, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Vorarlberg cohort (Ruttmann et al. Circulation 2005): in ~164,000 Austrian adults followed up to 17 years, GGT independently predicted cardiovascular mortality in both sexes, with risk rising even within the conventional reference range.
• Prospective diabetes analysis (Lee et al. Diabetologia 2003): GGT predicted incident type 2 diabetes in a graded fashion across its whole range, consistent with GGT marking early hepatic insulin resistance and oxidative stress.
• Guideline context (RCPA reference intervals): sex-specific Australian intervals anchor interpretation, with persistent unexplained elevation warranting assessment of alcohol, adiposity, medications and biliary health.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets GGT against published clinical authority standards, never arbitrary "optimal" ranges. Measured in U/L:

Band	Range (U/L)
Optimal	Male: <60; Female: <38 U/L
High	Male: 60–120; Female: 38–120 U/L
Very high	>120 U/L

Clinical interpretation

• The most sensitive liver enzyme for alcohol-related damage and bile duct obstruction.
• Also elevated by medications (anticonvulsants, NSAIDs), obesity, and metabolic syndrome.
• GGT in the upper-normal range independently predicts cardiovascular mortality and diabetes risk.

What improves it: the evidence-based levers

• Reduce alcohol
• Improve insulin sensitivity
• Weight reduction

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How GGT testing works at HodieLabs

GGT is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Ruttmann E, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality (Vorarlberg Health Monitoring and Promotion Program). Circulation. 2005;112:2130–2137.
2. Lee DH, et al. Gamma-glutamyltransferase and diabetes, a 4 year follow-up study. Diabetologia. 2003;46:359–364.
3. Royal College of Pathologists of Australasia. RCPA Manual: gamma-glutamyl transferase reference intervals.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.